STOCK TITAN

Institutional Position: Dimensional Reports 5.1% of Avanos (AVNS)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Dimensional Fund Advisors LP reports ownership of 2,352,634 shares of Avanos Medical Inc common stock, representing 5.1% of the outstanding class. The filing shows Dimensional has sole voting power over 2,282,916 shares and sole dispositive power over 2,352,634 shares, while disclaiming beneficial ownership because the shares are owned by client Funds. The statement clarifies these holdings are managed in an advisory capacity for multiple commingled funds and separate accounts and are held in the ordinary course of business without intent to influence control.

Positive

  • Holding exceeds 5% threshold, providing transparent disclosure of institutional exposure (2,352,634 shares, 5.1%)
  • Sole voting and dispositive power reported for most shares (voting power on 2,282,916 shares; dispositive power on 2,352,634)

Negative

  • None.

Insights

Large advisory stake signals passive institutional exposure, not a control intent.

The filing discloses an advisory position of 2,352,634 shares equal to 5.1% of the class, which crosses the 5% reporting threshold and can affect float and investor perception. The votes reported—2,282,916 shares with sole voting power—mean the adviser can direct votes associated with most of that stake on behalf of client Funds.

Risks and dependencies include the fact that the securities are held for multiple Funds that may change allocations; the filer expressly disclaims beneficial ownership, indicating investment decisions rest with underlying Funds or mandate constraints. Monitor any future amendments or Form 13D filings for shifts in intent or concentration.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



Dimensional Fund Advisors LP
Signature:Selwyn Notelovitz
Name/Title:Global Chief Compliance Officer
Date:10/09/2025

FAQ

What stake does Dimensional Fund Advisors LP report in Avanos Medical (AVNS)?

Dimensional reports ownership of 2,352,634 shares, representing 5.1% of Avanos Medical common stock.

How much voting power does Dimensional report for AVNS shares?

Dimensional reports sole voting power for 2,282,916 shares and shared voting power of 0 shares.

Does Dimensional claim beneficial ownership of the AVNS shares?

No. The filing states the shares are owned by client Funds and Dimensional disclaims beneficial ownership while reporting voting and dispositive powers as adviser.

Are these shares held for control purposes of Avanos (AVNS)?

The certification in the filing states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Who signed the Schedule 13G on behalf of Dimensional?

The filing is signed by Selwyn Notelovitz, listed as Global Chief Compliance Officer for Dimensional Fund Advisors LP.
Avanos Medical

NYSE:AVNS

AVNS Rankings

AVNS Latest News

AVNS Latest SEC Filings

AVNS Stock Data

529.18M
44.52M
4.07%
98.38%
5.89%
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States
ALPHARETTA